We wanted to share this article from NaturalHealth365 on how vitamin c therapy reduces inflammation in cancer patients.
At An Oasis Of Healing we agree that a primary marker of cancer is chronic inflammation. Using vitamin c therapy reduces inflammation which is why this treatment is part of our comprehensive cancer care program. This therapy challenges cancer cells at a metabolic level and does no harm to the body unlike conventional chemotherapy.
The value and impact of a daily vitamin C supplement as well as high, concentrated doses for acute illnesses is becoming increasingly clear. Studies have already shown the efficacy of liposomal vitamin C in treating infections and as an anti-cancer therapy. Now, another study is confirming its effectiveness against inflammation in cancer patients, one of the primary markers.
High levels of inflammation seem to indicate a higher risk of cancer as well as a less hopeful prognosis for healing and recovery. Inflammation impairs the immune system, plays a role in cachexia, lowers toleration of numerous cancer treatments, and generally decreases health and quality of life.
Warning: Chronic inflammation is one of the primary markers of cancer
The inflammatory response plays a major role in tumor development. Inflammation is a factor during numerous cancer phases including initiation, promotion, invasion and malignant conversion as well as metastasis. This connection between cancer and inflammation isn’t restricted to just one type of tumor, either. Inflammation can be a factor in the ecosystem of just about all types of neoplastic tissues.
The current amount of inflammation in the body can actually predict the chances and length of survival time for numerous types of cancer. Persons that have among the lowest inflammation levels are twice as likely to survive for at least two years with a cancer diagnosis.
This study made use of high-dose intravenous vitamin C (IVC) treatments and analyzed their effects. This was the first time this type of treatment was tested and studied specifically for its effects on inflammation in cancer patients.
High doses of vitamin C required for treating serious illnesses
The results found indicate great promise for the use of high-dose intravenous vitamin C treatments to help reduce inflammation in cancer patients, which is one of the major factors of cancer and its progression.
Over the past 35 years, the Riordan Clinic has had quite a bit of experience in administering extremely high doses of vitamin C to cancer patients. These tests for vitamin C have been conducted due to its proven value as a therapeutic and preventative measure.
Markers of inflammation such as pro-inflammatory cytokines and C-reactive protein tumor markers showed a positive response to vitamin C treatments, with inflammation reduced significantly. This improvement correlated with reduced tumor size and the hindrance of the cancer’s ability to metastasize.
Wide range of cancers respond positively to vitamin C therapy
Vitamin C is especially valuable in extremely high doses taken either orally or intravenously. A range of cancers have been proven to benefit from vitamin C treatments, including cancers of the prostate, breast, skin, bladder, lung, pancreas, thyroid, and B-cell lymphoma.
This research was conducted by Riordan Clinic scientists and published in the Journal of Translational Medicine. When supplementing with liposomal vitamin C orally for major health issues, 10,000 to 12,000 mg per day should be taken. This dose can be taken in 2,000 to 4,000 mg doses gradually throughout the day to aid absorption.
This article on how vitamin c therapy reduces inflammation first appeared on NaturalHealth365 www.naturalhealth365.com/vitamin-c-inflammation-2045.html.